|1.||Khalili, Kamel: 32 articles (01/2015 - 02/2002)|
|2.||Del Valle, Luis: 21 articles (01/2014 - 02/2002)|
|3.||Pipas, James M: 15 articles (05/2015 - 02/2002)|
|4.||Butel, Janet S: 13 articles (10/2012 - 02/2002)|
|5.||Khalili, K: 12 articles (04/2007 - 05/2000)|
|6.||Del Valle, L: 11 articles (07/2014 - 07/2000)|
|7.||Gordon, Jennifer: 11 articles (01/2013 - 02/2002)|
|8.||Muller, William J: 10 articles (01/2014 - 12/2003)|
|9.||Green, Jeffrey E: 10 articles (01/2011 - 05/2002)|
|10.||Vilchez, Regis A: 10 articles (02/2009 - 02/2002)|
10/01/1989 - "Thus, the disease-free rate (continuous complete response) in patients with tumors positive for T antigen was 81%, while that in patients with tumors negative for T antigen was 11% (p less than 0.005, chi-square test). "
10/01/1989 - "Of the patients 16 had positive T antigen expression in the tumors: 13 (81%) remained free of tumor for an average of 28 months, 3 had a noninvasive recurrence each at 8 to 27 months (mean 18 months) and all responded well to a repeated treatment cycle. "
01/01/2015 - "Our previous study demonstrated that the polyomavirus middle T antigen (PyMT) oncogene can establish diverse tumor subtypes when broadly expressed within mouse mammary epithelial cells. "
01/01/2015 - "In order to understand its roles in tumorigenesis, we extended our studies to analyze tumors derived from polyomavirus middle T-antigen ANXA1 heterozygous (ANXA1(+/-) ) and ANXA1 null (ANXA1(-/-) ) mice. "
04/06/2012 - "Our previous studies suggest that the α2,3sialylated T-antigen (NeuAcα2,3Galβ1,3GalNac-) and associated glycan structures are likely to be elevated during cancer. "
01/01/2008 - "HDACi treatment also partially relieved the normal down-regulation of early transcription by T-antigen seen later in infection. "
01/01/2012 - "Genetic studies of MCV have shown that T antigen protein is responsible for replication of genome and play a foremost role in viral infection. "
08/25/1999 - "To elucidate the role of small t antigen in cell cycle progression and in viral replication during infection, studies were performed using an SV40 mutant (dl888) that lacks the ability to produce small t. "
10/01/1993 - "In this study, a tumorigenic Sertoli cell line was developed by infection of isolated murine Sertoli cells by simian virus 40 tsA255; the ts mutation causes the inactivation of the large T antigen at elevated temperatures. "
01/01/1993 - "These studies examined cell cycle progression and quantitative changes in T-antigen following infection by SV40. "
04/01/1998 - "Similarly, we failed to detect expression of JC T antigen in any of 26 human glioma lines analyzed in this study. "
12/01/2000 - "From telomeres to T-antigens: many roads...multiple pathways...novel associations in the search for the origins of human gliomas."
05/01/2000 - "U1240Tag differs from U1240 glioma cells in that it expresses the SV40 large T antigen oncoprotein. "
01/01/2000 - "We have previously demonstrated that T antigen controls the JC virus basal promoter in a glial cell-specific manner, since T antigen repressed the JC virus and simian virus 40 (SV40) early promoters in glioma cells but induced strong activation of the JC virus early promoter in nonglial cells. "
01/01/1997 - "We investigated the presence of SV40 T antigen genome in 33 human glioma tissue specimens from Japanese patients with different histopathologies by means of the polymerase chain reaction (PCR) followed by Southern blotting. "
|4.||Hemophilia A (Haemophilia)
07/01/2006 - "The objective of this study was to compare the efficacy of eight Blastomyces dermatitidis yeast phase lysate antigens (T-58: dog, Tennessee; T-27: polar bear, Tennessee; ERC-2: dog, Wisconsin; B5894: human, Minnesota; SOIL: soil, Canada; B5896: human, Minnesota; 48089: human, Zaire; 48938: bat, India) in the detection of the immunoglobulins IgG and IgM in serum specimens from canines with blastomycosis. "
|2.||Immunoglobulin M (IgM)
|3.||Oncogene Proteins (Oncogene Protein)
|4.||Immunoglobulin G (IgG)
|6.||Deamino Arginine Vasopressin (Desmopressin)
|7.||Antiviral Agents (Antivirals)
|10.||Tumor Viral Antigens (Large T Antigen)
|3.||Heterologous Transplantation (Xenotransplantation)
|4.||Bone Marrow Transplantation (Transplantation, Bone Marrow)